浙江震元(000705) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was CNY 855,334,430.90, representing a 12.16% increase compared to CNY 762,595,784.50 in the same period last year[7] - Net profit attributable to shareholders was CNY 18,110,636.45, up 24.08% from CNY 14,596,215.38 year-on-year[7] - The net profit after deducting non-recurring gains and losses surged by 151.17%, reaching CNY 15,560,052.52 compared to CNY 6,194,980.64 in the previous year[7] - The basic earnings per share increased by 24.03% to CNY 0.0542 from CNY 0.0437 in the same period last year[7] - Operating profit increased by 54.50% to ¥20.13 million, attributed to higher sales revenue and improved profitability[14] - The company reported a total comprehensive income of RMB 40,641,553.80 for Q1 2021, compared to RMB 163,869.52 in Q1 2020[32] - The company achieved an operating profit of RMB 20,128,523.33, compared to RMB 13,028,403.05 in Q1 2020, marking a significant improvement[32] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,672,154,857.45, a decrease of 1.08% from CNY 2,701,279,049.18 at the end of the previous year[7] - The net assets attributable to shareholders increased by 2.11% to CNY 1,778,176,967.62 from CNY 1,741,455,077.20 at the end of the previous year[7] - Total assets reached RMB 2,672,154,857.45, a slight decrease from RMB 2,701,279,049.18 at the end of the previous year[30] - Total liabilities were RMB 877,097,708.64, down from RMB 939,286,554.16, showing a decrease of about 6.6%[30] - Current liabilities for the first quarter of 2021 were CNY 630,247,092.72, while total liabilities stood at CNY 734,528,156.01[27] Cash Flow - The net cash flow from operating activities was negative at CNY -149,399,290.61, worsening by 23.70% compared to CNY -120,777,772.38 in the same period last year[7] - The cash inflow from operating activities totaled RMB 836,652,908.66, slightly down from RMB 841,389,588.74 in the same period last year[34] - The cash outflow from operating activities was RMB 986,052,199.27, compared to RMB 933,356,499.18 in the previous year, resulting in a net cash flow from operating activities of -RMB 149,399,290.61[34] - Cash inflow from investment activities amounted to RMB 262,592,506.85, while cash outflow was RMB 111,816,498.55, leading to a net cash flow from investment activities of -RMB 111,814,398.55[34] - The ending cash and cash equivalents balance was RMB 154,193,990.38, down from RMB 465,666,159.54 at the beginning of the period[34] Shareholder Information - The company reported a total of 26,609 common shareholders at the end of the reporting period[10] - The largest shareholder, Shaoxing Zhenyuan Health Industry Group Co., Ltd., held 24.93% of the shares, amounting to 83,300,474 shares[10] Research and Development - Ongoing research and development efforts are focused on enhancing product offerings and technological advancements[31] - Research and development expenses increased to RMB 6,738,176.89, reflecting the company's commitment to innovation[32] Tax and Other Expenses - The company reported a 52.80% decrease in taxes payable, amounting to ¥38.84 million, due to the payment of prior year's deferred taxes[14] - Tax expenses for the quarter were RMB 1,434,217.84, slightly higher than RMB 1,432,732.17 in the same period last year[32] Future Plans - The company plans to expand its market presence and invest in new product development to drive future growth[31]